{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:02:15Z","timestamp":1779958935733,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int. J. Mach. Learn. & Cyber."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13042-026-03153-x","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:06:27Z","timestamp":1779955587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CLAT-DTA: a collaborative attention-based approach for drug-target binding affinity prediction"],"prefix":"10.1007","volume":"17","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"5","key":"3153_CR1","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jama.2020.8651","volume":"324","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M (2020) Luyten J (2020) Research and development costs of new drugs-reply. JAMA 324(5):518. https:\/\/doi.org\/10.1001\/jama.2020.8651","journal-title":"JAMA"},{"issue":"3","key":"3153_CR2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ (2020) Cragg G M (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83(3):770\u2013803","journal-title":"J Nat Prod"},{"issue":"6","key":"3153_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/cts.12577","volume":"11","author":"T Takebe","year":"2018","unstructured":"Takebe T, Imai R, Ono S (2018) The current status of drug discovery and development as originated in United States academia: the influence of industrial and academic collaboration on drug discovery and development. Clin Transl Sci 11(6):597\u2013606","journal-title":"Clin Transl Sci"},{"issue":"7","key":"3153_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41573-025-01164-x","volume":"24","author":"Z Tanoli","year":"2025","unstructured":"Tanoli Z, Fern\u00e1ndez-Torras A, \u00d6zcan UO et al (2025) Computational drug repurposing: approaches, evaluation of in silico resources and case studies. Nat Rev Drug Discovery 24(7):521\u2013542","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"3153_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13321-022-00591-x","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang J, Wen NF, Wang C et al (2022) ELECTRA-DTA: a new compound-protein binding affinity prediction model based on the contextualized sequence encoding. J Cheminfo 14(1):14","journal-title":"J Cheminfo"},{"issue":"1","key":"3153_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12859-024-05753-2","volume":"25","author":"X Zeng","year":"2024","unstructured":"Zeng X, Chen W, Lei B (2024) CAT-DTI: cross-attention and Transformer network with domain adaptation for drug-target interaction prediction. BMC Bioinformatics 25(1):141","journal-title":"BMC Bioinformatics"},{"key":"3153_CR7","first-page":"729","volume":"2022","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee S, Ghosh M, Basuchowdhuri P (2022) DeepGLSTM: deep graph convolutional network and LSTM based approach for predicting drug-target binding affinity[C]\/\/Proceedings of the 2022 SIAM international conference on data mining (SDM). Soc Indus Appl Math 2022:729\u2013737","journal-title":"Soc Indus Appl Math"},{"issue":"3","key":"3153_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1039\/D1SC05180F","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Zhong W, Zhao L et al (2022) MGraphDTA: deep multiscale graph neural network for explainable drug\u2013target binding affinity prediction. Chem Sci 13(3):816\u2013833","journal-title":"Chem Sci"},{"issue":"2","key":"3153_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s42256-022-00605-1","volume":"5","author":"P Bai","year":"2023","unstructured":"Bai P, Miljkovi\u0107 F, John B et al (2023) Interpretable bilinear attention network with domain adaptation improves drug\u2013target prediction. Nat Mach Intell 5(2):126\u2013136","journal-title":"Nat Mach Intell"},{"key":"3153_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ins.2022.09.043","volume":"613","author":"Z Chu","year":"2022","unstructured":"Chu Z, Huang F, Fu H et al (2022) Hierarchical graph representation learning for the prediction of drug-target binding affinity. Inf Sci 613:507\u2013523","journal-title":"Inf Sci"},{"issue":"6","key":"3153_CR11","doi-asserted-by":"publisher","first-page":"bbaf625","DOI":"10.1093\/bib\/bbaf625","volume":"26","author":"S Savander","year":"2025","unstructured":"Savander S, Curabaz NN, Abbasi AM et al (2025) Data-driven strategies for drug repurposing: insights, recommendations, and case studies. Brief Bioinform 26(6):bbaf625","journal-title":"Brief Bioinform"},{"key":"3153_CR12","doi-asserted-by":"crossref","unstructured":"\u00d6zt\u00fcrk H, Ozkirimli E, \u00d6zg\u00fcr A (2019) WideDTA: prediction of drug-target binding affinity[J]. arXiv preprint arXiv:1902.04166","DOI":"10.1093\/bioinformatics\/bty593"},{"key":"3153_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa524","author":"C Lifan","year":"2020","unstructured":"Lifan C, Xiaoqin T, Dingyan W et al (2020) TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa524","journal-title":"Bioinformatics"},{"key":"3153_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/bioinformatics\/btac155","volume":"9","author":"W Yifan","year":"2022","unstructured":"Yifan W, Min G, Min Z et al (2022) (2022) BridgeDPI: a novel Graph Neural Network for predicting drug-protein interactions. Bioinformatics 9:9. https:\/\/doi.org\/10.1093\/bioinformatics\/btac155","journal-title":"Bioinformatics"},{"key":"3153_CR15","doi-asserted-by":"crossref","unstructured":"Xiao X, Wang W, Xie J, et al (2024) HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction[J]. arXiv preprint arXiv:2406.17697","DOI":"10.1007\/978-981-96-6585-3_24"},{"issue":"11","key":"3153_CR16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S et al (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 29(11):1046\u20131051","journal-title":"Nat Biotechnol"},{"issue":"3","key":"3153_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1021\/ci400709d","volume":"54","author":"J Tang","year":"2014","unstructured":"Tang J, Szwajda A, Shakyawar S et al (2014) Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis. J Chem Inf Model 54(3):735\u2013743","journal-title":"J Chem Inf Model"},{"key":"3153_CR18","doi-asserted-by":"crossref","unstructured":"Tang J, Ravikumar B, Alam Z (2018) Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions[J]. Cell Chem Biol 25(2):224\u2013229 (e2)","DOI":"10.1016\/j.chembiol.2017.11.009"},{"issue":"4","key":"3153_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nchembio.530","volume":"7","author":"JT Metz","year":"2011","unstructured":"Metz JT, Johnson EF, Soni NB et al (2011) Navigating the kinome. Nat Chem Biol 7(4):200\u2013202","journal-title":"Nat Chem Biol"},{"key":"3153_CR20","unstructured":"Kingma DP, Adam BJ (2014) A method for stochastic optimization[J]. arXiv preprint arXiv:1412.6980"},{"key":"3153_CR21","doi-asserted-by":"crossref","unstructured":"Tang J, Ravikumar B, Alam Z (2018) Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions [J]. Cell Chem Biol 25(2):224\u2013229 (e2)","DOI":"10.1016\/j.chembiol.2017.11.009"},{"issue":"6","key":"3153_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/ci010132r","volume":"42","author":"JL Durant","year":"2002","unstructured":"Durant JL, Leland BA, Henry DR et al (2002) Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci 42(6):1273\u20131280","journal-title":"J Chem Inf Comput Sci"},{"issue":"15","key":"3153_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016239118","volume":"118","author":"A Rives","year":"2021","unstructured":"Rives A, Meier J, Sercu T et al (2021) Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proc Natl Acad Sci 118(15):e2016239118","journal-title":"Proc Natl Acad Sci"},{"key":"3153_CR24","first-page":"1301","volume":"2020","author":"X Lin","year":"2020","unstructured":"Lin X, Zhao K, Xiao T et al (2020) DeepGS: Deep representation learning of graphs and sequences for drug-target binding affinity prediction[M]\/\/ECAI 2020. IOS Press 2020:1301\u20131308","journal-title":"IOS Press"},{"issue":"8","key":"3153_CR25","doi-asserted-by":"publisher","first-page":"btae496","DOI":"10.1093\/bioinformatics\/btae496","volume":"40","author":"A Schulman","year":"2024","unstructured":"Schulman A, Rousu J, Aittokallio T et al (2024) Attention-based approach to predict drug-target interactions across seven target superfamilies. Bioinformatics 40(8):btae496","journal-title":"Bioinformatics"},{"key":"3153_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.neunet.2023.11.018","volume":"169","author":"H Wu","year":"2024","unstructured":"Wu H, Liu J, Jiang T et al (2024) AttentionMGT-DTA: amulti-modal drug-target affinity prediction using graph transformer and attention mechanism. Neural Netw 169:623\u2013636","journal-title":"Neural Netw"},{"key":"3153_CR27","doi-asserted-by":"crossref","unstructured":"Li M, Wang Y, Guo P, et al (2025) HiF-DTA: Hierarchical Feature Learning Network for Drug-Target Affinity Prediction[J]. arXiv preprint arXiv:2510.27281","DOI":"10.1109\/BIBM66473.2025.11356849"},{"issue":"2","key":"3153_CR28","doi-asserted-by":"publisher","first-page":"btad056","DOI":"10.1093\/bioinformatics\/btad056","volume":"39","author":"Y Hua","year":"2023","unstructured":"Hua Y, Song X, Feng Z et al (2023) MFR-DTA: a multi-functional and robust model for predicting drug-target binding affinity and region. Bioinformatics 39(2):btad056","journal-title":"Bioinformatics"},{"issue":"3","key":"3153_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011036","volume":"19","author":"M Kalemati","year":"2023","unstructured":"Kalemati M, Zamani Emani M, Koohi S (2023) BiComp-DTA: Drug-target binding affinity prediction through complementary biological-related and compression-based featurization approach. PLoS Comput Biol 19(3):e1011036","journal-title":"PLoS Comput Biol"},{"issue":"17","key":"3153_CR30","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1021\/acs.jpclett.1c00867","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zhong W, Zhao L et al (2021) ML-DTI: mutual learning mechanism for interpretable drug\u2013target interaction prediction. J Phys Chem Lett 12(17):4247\u20134261","journal-title":"J Phys Chem Lett"},{"issue":"2","key":"3153_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/bib\/bbu010","volume":"16","author":"T Pahikkala","year":"2015","unstructured":"Pahikkala T, Airola A, Pietil\u00e4 S et al (2015) Toward more realistic drug\u2013target interaction predictions. Brief Bioinform 16(2):325\u2013337","journal-title":"Brief Bioinform"},{"issue":"17","key":"3153_CR32","doi-asserted-by":"publisher","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk H, \u00d6zg\u00fcr A, Ozkirimli E (2018) DeepDTA: deep drug-target binding affinity prediction. Bioinformatics 34(17):i821\u2013i829","journal-title":"Bioinformatics"},{"key":"3153_CR33","first-page":"1","volume":"9","author":"T He","year":"2017","unstructured":"He T, Heidemeyer M, Ban F et al (2017) SimBoost: a read-across approach for predicting drug\u2013target binding affinities using gradient boosting machines. J Chem 9:1\u201314","journal-title":"J Chem"},{"issue":"4","key":"3153_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215140","volume":"14","author":"S Berndt","year":"2019","unstructured":"Berndt S, Gurevich VV, Iverson TM (2019) Crystal structure of the SH3 domain of human Lyn non-receptor tyrosine kinase. PLoS ONE 14(4):e0215140","journal-title":"PLoS ONE"},{"issue":"D1","key":"3153_CR35","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhao D et al (2024) TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res 52(D1):D1465\u2013D1477","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3153_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/leu.2008.334","volume":"23","author":"LL Remsing Rix","year":"2009","unstructured":"Remsing Rix LL, Rix U, Colinge J et al (2009) Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia 23(3):477\u2013485","journal-title":"Leukemia"},{"issue":"4","key":"3153_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1087057112466430","volume":"18","author":"S Ahmad","year":"2013","unstructured":"Ahmad S, Hughes MA, Johnson GL et al (2013) Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors. J Biomol Screen 18(4):388\u2013399","journal-title":"J Biomol Screen"},{"key":"3153_CR38","first-page":"99","volume":"2013","author":"GK Amsberg","year":"2013","unstructured":"Amsberg GK, Koschmieder S (2013) Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia. Onco Targets Ther 2013:99\u2013106","journal-title":"Onco Targets Ther"},{"issue":"3","key":"3153_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/leu.2008.334","volume":"23","author":"LL Remsing Rix","year":"2009","unstructured":"Remsing Rix LL, Rix U, Colinge J et al (2009) Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia 23(3):477\u2013485","journal-title":"Leukemia"}],"container-title":["International Journal of Machine Learning and Cybernetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13042-026-03153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13042-026-03153-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13042-026-03153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:06:33Z","timestamp":1779955593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13042-026-03153-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1007\/s13042-026-03153-x","relation":{},"ISSN":["1868-8071","1868-808X"],"issn-type":[{"value":"1868-8071","type":"print"},{"value":"1868-808X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data used in this project is publicly available and does not require additional consent for its use.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical and informed consent for data used"}}],"article-number":"325"}}